폐루프 신경조절 프로세서 시장 보고서(2026년)
Closed-Loop Neuromodulation Processor Global Market Report 2026
상품코드 : 1942576
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,689,000
PDF & Excel (Single User License) help
PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,668,000
PDF & Excel (Site License) help
PDF & Excel 보고서를 동일 기업의 동일 사업장 내의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,648,000
PDF & Excel (Enterprise License) help
PDF & Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

폐 루프 신경조절 프로세서 시장의 규모는 최근 급속히 확대하고 있습니다. 2025년 25억 2,000만 달러에서 2026년에는 28억 5,000만 달러로, CAGR 13.2%로 성장이 전망되고 있습니다. 지난 수년간의 성장은 신경질환의 유병률 증가, 정밀한 신경조절에 대한 수요, 이식형 디바이스의 발전, DBS/SCS 시스템의 채택 확대, 신경기술 분야의 연구자금 증가에 기인하는 것으로 보입니다.

폐 루프 신경조절 프로세서 시장 규모는 향후 수년간 급성장이 전망됩니다. 2030년에는 46억 3,000만 달러에 달하며, CAGR은 12.9%에 달할 전망입니다. 예측 기간 중의 성장 요인으로는 AI 기반 적응형 프로세서 개발, 외부 장착형 컨트롤러의 보급 확대, 원격의료와의 통합, 재택 신경조절 치료의 성장, 신흥 시장에서의 채택 증가 등을 꼽을 수 있습니다. 예측 기간의 주요 동향에는 실시간 신경 피드백, 적응형 자극 알고리즘, 웨어러블 컨트롤러와의 통합, 원격 모니터링 기능, 멀티모달 치료의 최적화 등이 포함됩니다.

신경질환의 유병률 증가는 폐쇄 루프 신경조절 프로세서 시장의 성장을 지원할 것으로 예측됩니다. 신경질환이란 뇌, 척수, 말초신경에 영향을 미쳐 운동기능, 인지기능, 감각기능에 문제를 일으키는 신경계 기능장애를 말합니다. 신경질환 증가는 주로 전 세계 고령화에 기인하며, 알츠하이머병, 파킨슨병 등의 발병률 상승으로 이어지고 있습니다. 폐루프 신경조절 프로세서는 뇌 활동을 지속적으로 추적하고, 비정상적인 신경 패턴을 조절하기 위해 실시간으로 표적화된 전기 자극을 공급함으로써 이러한 질환의 관리를 돕습니다. 예를 들어 미국에 본사를 둔 연구기관인 건강지표평가연구소(IHME)에 따르면 2022년에는 신경질환이 전 세계 인구의 43%에게 영향을 미치고 있으며, 이 수치는 2050년까지 두 배로 늘어날 수 있다고 합니다. 이러한 부담 증가는 폐쇄형 신경조절 프로세서 시장의 확대에 기여하고 있습니다.

폐쇄형 신경조절 프로세서 시장에서 사업을 운영하는 기업은 뇌-컴퓨터 인터페이스 기술을 통합하여 치료의 정확도 향상, 증상 관리 강화, 신경질환 환자 개개인의 맞춤형 치료 실현을 통해 맞춤 치료 옵션을 추진하고 있습니다. 뇌-컴퓨터 인터페이스는 신경 활동을 감지하고 해석하여 실행 가능한 명령어로 변환함으로써 뇌와 외부 장치 간의 직접적인 상호작용을 가능하게 하는 시스템입니다. 이러한 인터페이스는 종종 신경조절 장치나 재활 장비에 내장되어 환자의 뇌 신호에 기반한 실시간 모니터링과 적응형 자극을 가능하게 합니다. 예를 들어 2025년 2월 미국 의료 기술 기업 메드트로닉(Medtronic)은 미국 식품의약국(FDA)으로부터 'BrainSense Adaptive Deep Brain Stimulation' 및 'BrainSense Electrode Identifier'를 승인받았습니다. 의 승인을 획득했습니다. 이는 당시 뇌-컴퓨터 인터페이스 기술에서 가장 큰 상업적 발전이 되었습니다. 이 시스템은 뇌 활동을 지속적으로 모니터링하고 자극을 자동으로 조절하여 파킨슨병 환자 개개인에 맞는 치료를 실현합니다. 임상연구에서 기존 심부뇌자극술과 비교하여 증상 관리 개선, 운동 변동성 감소, 환자의 치료 결과 개선이 확인되었습니다.

목차

제1장 개요

제2장 시장의 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 용도 산업의 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의에 의한 공급망에 대한 영향, Covid가 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 시장의 세계 TAM(Total Addressable Market)

제9장 시장 세분화

제10장 지역별·국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 대기업과 혁신적 기업

제38장 세계의 시장 경쟁 벤치마킹과 대시보드

제39장 주요 합병과 인수

제40장 시장의 잠재력이 높은 국가, 부문, 전략

제41장 부록

KSA
영문 목차

영문목차

A closed-loop neuromodulation processor is a medical device that monitors neural activity in real time and automatically adjusts electrical stimulation based on feedback. It enables precise regulation of nervous system function, supporting effective and targeted treatment of neurological disorders.

The primary product types of closed-loop neuromodulation processors include implantable processors and external processors. Implantable processors are internal devices that deliver precise neural stimulation based on continuous physiological feedback. Technologies in these processors include deep brain stimulation, spinal cord stimulation, vagus nerve stimulation, and others. Key application areas encompass chronic pain management, epilepsy, Parkinson's disease, depression, and other neurological conditions. These devices are primarily used in hospitals, specialty clinics, research institutes, and other healthcare settings.

Tariffs are impacting the closed-loop neuromodulation processor market by raising the cost of imported implantable processors, wearable controllers, and pulse generators. Hospitals, specialty clinics, and research institutes are most affected. The most impacted segments include DBS and SCS processors, particularly in Asia-Pacific regions. Positive impacts include incentivizing local manufacturing and fostering innovation in cost-effective adaptive neuromodulation technologies.

The closed-loop neuromodulation processor market research report is one of a series of new reports from The Business Research Company that provides closed-loop neuromodulation processor market statistics, including closed-loop neuromodulation processor industry global market size, regional shares, competitors with a closed-loop neuromodulation processor market share, detailed closed-loop neuromodulation processor market segments, market trends and opportunities, and any further data you may need to thrive in the closed-loop neuromodulation processor industry. This closed-loop neuromodulation processor market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The closed-loop neuromodulation processor market size has grown rapidly in recent years. It will grow from $2.52 billion in 2025 to $2.85 billion in 2026 at a compound annual growth rate (CAGR) of 13.2%. The growth in the historic period can be attributed to growing prevalence of neurological disorders, demand for precise neuromodulation, advancements in implantable devices, adoption of DBS/SCS systems, increasing research funding in neurotech.

The closed-loop neuromodulation processor market size is expected to see rapid growth in the next few years. It will grow to $4.63 billion in 2030 at a compound annual growth rate (CAGR) of 12.9%. The growth in the forecast period can be attributed to development of AI-enabled adaptive processors, expansion of external wearable controllers, integration with telemedicine, growth in home-based neuromodulation therapy, rising adoption in emerging markets. Major trends in the forecast period include real-time neural feedback, adaptive stimulation algorithms, integration with wearable controllers, remote monitoring capabilities, multimodal therapy optimization.

The increasing prevalence of neurological disorders is expected to support the growth of the closed-loop neuromodulation processor market. A neurological disorder is a condition that disrupts the function of the nervous system, affecting the brain, spinal cord, or peripheral nerves, and can result in challenges related to movement, cognition, or sensation. The rise in neurological disorders is largely attributed to an aging global population, which has led to a higher incidence of conditions such as Alzheimer's disease and Parkinson's disease. Closed-loop neuromodulation processors assist in managing these conditions by continuously tracking brain activity and delivering targeted electrical stimulation in real time to regulate abnormal neural patterns. For example, according to the Institute for Health Metrics and Evaluation, a research organization based in the United States, neurological conditions impacted 43 percent of the global population in 2022, with projections suggesting this figure could double by the year 2050. This growing burden is contributing to the expansion of the closed-loop neuromodulation processor market.

Companies operating in the closed-loop neuromodulation processor market are advancing personalized treatment options by integrating brain-computer interface technology to improve therapeutic precision, enhance symptom control, and tailor care to individual patients with neurological disorders. A brain-computer interface is a system that facilitates direct interaction between the brain and an external device by detecting, interpreting, and converting neural activity into actionable commands. These interfaces are often embedded in neuromodulation or rehabilitation devices, allowing real-time monitoring and adaptive stimulation based on a patient's brain signals. For instance, in February 2025, Medtronic plc, a medical technology company based in the United States, received approval from the United States Food and Drug Administration for its BrainSense Adaptive Deep Brain Stimulation and BrainSense Electrode Identifier. This represented the largest commercial deployment of brain-computer interface technology to date. The system continuously monitors brain activity and adjusts stimulation automatically, personalizing therapy for individuals with Parkinson's disease. Clinical studies showed improved symptom management, reduced motor fluctuations, and better patient outcomes when compared to traditional deep brain stimulation methods.

In September 2023, Amber Therapeutics Ltd., a biotechnology research company based in the United Kingdom, acquired Bioinduction Limited for an undisclosed amount. The goal of this acquisition was to strengthen Amber Therapeutics' presence in the closed-loop neuromodulation space by incorporating Bioinduction's Picostim DyNeuMo system, a compact cranial neurostimulator. Bioinduction Limited is a medical equipment manufacturer based in the United Kingdom, specializing in closed-loop neuromodulation technologies.

Major companies operating in the closed-loop neuromodulation processor market are Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, Beijing PINS Medical, CorTec, NeuroPace, Saluda Medical, NeuSpera Medical, Inbrain Neuroelectronics, Blackrock Neurotech, Great Lakes NeuroTechnologies, SensArs Neuroprosthetics, BioControl Medical, Precision Neuroscience, Motif Neurotech, Synergia Medical, BrainQ Technologies, Soterix Medical (partially relevant), Synergia Medical, Inbrain Neuroelectronics

North America was the largest region in the closed-loop neuromodulation processor market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the closed-loop neuromodulation processor market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the closed-loop neuromodulation processor market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The closed-loop neuromodulation processor market consists of revenues earned by entities by providing services such as adaptive neurostimulation programming, real-time monitoring, and clinical support. The market value includes the value of related goods sold by the service provider or included within the service offering. The closed-loop neuromodulation processor market also includes sales of implantable neuromodulation devices, sensing-enabled processors, and connected software platforms. Values in this market are 'factory gate' values the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value also includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Closed-Loop Neuromodulation Processor Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses closed-loop neuromodulation processor market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for closed-loop neuromodulation processor ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The closed-loop neuromodulation processor market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

2. Closed-Loop Neuromodulation Processor Market Characteristics

3. Closed-Loop Neuromodulation Processor Market Supply Chain Analysis

4. Global Closed-Loop Neuromodulation Processor Market Trends And Strategies

5. Closed-Loop Neuromodulation Processor Market Analysis Of End Use Industries

6. Closed-Loop Neuromodulation Processor Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Closed-Loop Neuromodulation Processor Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

8. Global Closed-Loop Neuromodulation Processor Total Addressable Market (TAM) Analysis for the Market

9. Closed-Loop Neuromodulation Processor Market Segmentation

10. Closed-Loop Neuromodulation Processor Market Regional And Country Analysis

11. Asia-Pacific Closed-Loop Neuromodulation Processor Market

12. China Closed-Loop Neuromodulation Processor Market

13. India Closed-Loop Neuromodulation Processor Market

14. Japan Closed-Loop Neuromodulation Processor Market

15. Australia Closed-Loop Neuromodulation Processor Market

16. Indonesia Closed-Loop Neuromodulation Processor Market

17. South Korea Closed-Loop Neuromodulation Processor Market

18. Taiwan Closed-Loop Neuromodulation Processor Market

19. South East Asia Closed-Loop Neuromodulation Processor Market

20. Western Europe Closed-Loop Neuromodulation Processor Market

21. UK Closed-Loop Neuromodulation Processor Market

22. Germany Closed-Loop Neuromodulation Processor Market

23. France Closed-Loop Neuromodulation Processor Market

24. Italy Closed-Loop Neuromodulation Processor Market

25. Spain Closed-Loop Neuromodulation Processor Market

26. Eastern Europe Closed-Loop Neuromodulation Processor Market

27. Russia Closed-Loop Neuromodulation Processor Market

28. North America Closed-Loop Neuromodulation Processor Market

29. USA Closed-Loop Neuromodulation Processor Market

30. Canada Closed-Loop Neuromodulation Processor Market

31. South America Closed-Loop Neuromodulation Processor Market

32. Brazil Closed-Loop Neuromodulation Processor Market

33. Middle East Closed-Loop Neuromodulation Processor Market

34. Africa Closed-Loop Neuromodulation Processor Market

35. Closed-Loop Neuromodulation Processor Market Regulatory and Investment Landscape

36. Closed-Loop Neuromodulation Processor Market Competitive Landscape And Company Profiles

37. Closed-Loop Neuromodulation Processor Market Other Major And Innovative Companies

38. Global Closed-Loop Neuromodulation Processor Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Closed-Loop Neuromodulation Processor Market

40. Closed-Loop Neuromodulation Processor Market High Potential Countries, Segments and Strategies

41. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기